The Newborn Metabolic Screening Market To Grow Diligently Between 2030

Category: Others/ Misc

Presentation Description

According to a latest report published by Persistence Market Research, the global newborn metabolic screening market was valued around US$ 247 Mn in 2020, and is expected to witness an impressive CAGR of over 9% during the forecast period (2020 – 2030).


Presentation Transcript

Newborn Metabolic Screening Market:

Newborn Metabolic Screening Market Report Id : PMRREP31998 Category : Life Science & Healthcare ©2020 Persistence Market Research, All Rights Reserved

About Persistence Market Research:

About Persistence Market Research For detailed subscription information please contact Website: For sales queries or new topics email us on: Subscription Information Research Capabilities Customized Research Syndicated Research Investment Research Social Media Research Sector Coverage Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Social Media Research Investment Research Customized Research Syndicated Research Persistence Market Research(Persistence Market Research) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. Persistence Market Research is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for our client. 2

How Would Global Contribute To The Growth Of The Newborn Metabolic Screening Market?:

Increasing birth rates across the world are expected to drive demand for newborn metabolic screening, as the risk of galactosemia , sickle cell disease, phenylketonuria, maple syrup urine disease, and cystic fibrosis is higher among infants. Various countries are implementing screening for metabolic diseases in newborns as a part of their immunization programs. To remain competitive and ensure a robust product pipeline, leading companies continue to identify potential assets through pilot screening programs, which typically have limited resources to see projects through the market. According to a latest report published by Persistence Market Research, the global newborn metabolic screening market was valued around US$ 247 Mn in 2020, and is expected to witness an impressive CAGR of over 9% during the forecast period (2020 – 2030). 3 Get Sample Copy of Report @ How Would Global Contribute To The Growth Of The Newborn Metabolic Screening Market ?

Key Takeaways from Market Study:

Key Takeaways from Market Study 4 Access Full Report @ Sickle cell disease is expected to contribute more than 30% of revenue share to the market. By sample, blood testing held the highest market share in 2019 due to efficient diagnostic results. Europe holds a significant share of over 30% in the global newborn metabolic screening market. Leading manufacturers are focused on strengthening their product portfolios and regional expansion through collaborations. Hospitals are expected to hold significant market share, due to high number of screening programs being arranged in collaboration with hospitals. The COVID-19 outbreak has had a negative impact on the market, as short-term lockdowns disturbed the production and supply chain of kits. The market in the U.S is projected to expand at a CAGR of close to 10% through 2030. The U.K market has a share of more than 17% in Europe, and is expected to progress at a CAGR of more than 12% over the next ten years. “ Increasing prevalence of new born metabolic diseases and rising adoption of related screening program will boost the global market,”  says an analyst of Persistence Market Research.



authorStream Live Help